{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:11:54Z","timestamp":1779189114639,"version":"3.51.4"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770213"],"award-info":[{"award-number":["81770213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune checkpoints, including PD\u20101\/PD\u2010L1, play an important role in immunosuppression in various malignancies. Elevated levels of soluble programmed death ligand 1 (sPD\u2010L1) are associated with worse prognosis in multiple myeloma and diffuse large B cell lymphoma. Herein, the purpose of this study is to investigate the relationships between plasma sPD\u2010L1 levels and clinical response in peripheral T\u2010cell lymphoma (PTCL) patients.<\/jats:p>\n                  <jats:p>A total of 37 PTCL patients and 20 healthy volunteers were enrolled. Peripheral blood from patients was collected prior to systemic therapy. Plasma levels of sPD\u2010L1 and IFN\u2010\u03b3 were measured by enzyme\u2010linked immunosorbent assay (ELISA). PD\u2010L1 expression in tissues was detected by immunohistochemistry (IHC). Clinical response for patients was evaluated.<\/jats:p>\n                  <jats:p>\n                    ONCOMINE database analyses showed that PD\u2010L1 mRNA expression was significantly upregulated in PTCLs. The median sPD\u2010L1 level was 0.729\u00a0ng\/mL for 20 healthy volunteers and 1.696\u00a0ng\/mL for 37 PTCL patients which was significantly higher than that in healthy volunteers (0.000). The sPD\u2010L1 level was positively correlated with IFN\u2010\u03b3 level (0.000,\n                    <jats:italic>r<\/jats:italic>\n                    \u00a0=\u00a00.849) and was also positively associated with clinical staging (0.045), LDH level (0.003), and \u03b22\u2010MG level (0.045). Patients with high sPD\u2010L1 level had lower overall response rate than those with low sPD\u2010L1 level (88.9% vs 50.0%, 0.022) and tended to have poorer PFS and OS. PD\u2010L1 expression in tissues matched very well with the sPD\u2010L1 level in PTCL patients. In conclusion, PTCL patients had higher sPD\u2010L1 level compared with healthy volunteers. High sPD\u2010L1 level was correlated with worse clinical response, suggesting that sPD\u2010L1 level was an underlying plasma biomarker to predict the prognosis for PTCL patients.\n                  <\/jats:p>","DOI":"10.1002\/hon.2636","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T08:34:27Z","timestamp":1557477267000},"page":"270-276","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T\u2010cell lymphomas"],"prefix":"10.1002","volume":"37","author":[{"given":"Xuhan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"},{"name":"Department of Radiotherapy Oncology Cangzhou Central Hospital  Hebei China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzi","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pathology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pathology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Immunology\/Biotherapy Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-2923","authenticated-orcid":false,"given":"Xianhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino\u2010US Center for Lymphoma and Leukemia Research  Tianjin China"},{"name":"Department of Pathology and Microbiology University of Nebraska Medical Center  Omaha NE USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08651.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2428"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31107"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090331"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2326"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31357"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21775"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.117"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1054"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4303"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-2988-5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131403"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629600"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11045"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0250"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.137"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30501"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-016-0401-9"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.02.032"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.06.004"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1139\/O09-015"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00030-3"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.12.093"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5682"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1269047"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17022"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2016.12.43"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-1987-x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0013"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hon.2636","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T20:08:35Z","timestamp":1694030915000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1002\/hon.2636"],"URL":"https:\/\/doi.org\/10.1002\/hon.2636","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/HON.2636\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2636\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2636\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2636\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2636\/v2\/decision1","asserted-by":"object"}]},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]},"assertion":[{"value":"2019-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}